Metraipolis › archive › dc_a5bbfa9e7723

Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor Microenvironment — Europe PMC PMID:42346215

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346215
DOI
10.3390/curroncol33060315
License (as archived)
solo-consultazione
Archived
2026-10-08T07:41:24.791Z
SHA-256 of the archived text
65b509e868e472602dda47f7a0b8a172676cbc409b03e29e66b12856a2094b24
Stable URL of this page
https://metraipolis.com/documento/dc_a5bbfa9e7723

How to cite

Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor Microenvironment — Europe PMC PMID:42346215 — Europe PMC (en), https://europepmc.org/article/MED/42346215 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5bbfa9e7723 (Metraipolis archive dc_a5bbfa9e7723, sha256 65b509e868e472602dda47f7a0b8a172676cbc409b03e29e66b12856a2094b24)
BibTeX
@misc{dca5bbfa9e7723,
  title = {Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor Microenvironment — Europe PMC PMID:42346215},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346215},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5bbfa9e7723; sha256 65b509e868e472602dda47f7a0b8a172676cbc409b03e29e66b12856a2094b24},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346215. Agents can read the archived copy with the MCP tool read_document.